MedTrace Logo

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet Under Fasting and Fed

NCT00883506 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-03-29

No results posted yet for this study

Summary

To Demonstrate the Relative Bioequivalence of Lisinopril 1 x 40 mg Tablet under Fasting and Fed.

Conditions

Interventions

DRUG

Lisinopril 40 mg Tablet (Zestril) under fed conditions.

DRUG

Lisinopril 40 mg Tablet under fasting conditions.

DRUG

Lisinopril 40 mg Tablet under fed conditions.

Sponsors & Collaborators

Principal Investigators

  • Eric Masson, Pharm.D. · Anapharm

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-05-31
Primary Completion
2000-06-30
Completion
2000-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00883506 on ClinicalTrials.gov